跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
达英-35 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Ethinylestradiol and Cyproterone Acetate Tablets
Approved
化学药品
Ethinylestradiol and Cyproterone Acetate Tablets
BAYER (SOUTH EAST ASIA) PTE LTD
🇨🇳 National Medical Products Administration
Approval Date
Jan 4, 2023
Approval ID
30bba454f53ba2ec
Company
BAYER (SOUTH EAST ASIA) PTE LTD
Type
化学药品
Approval Details
Approval Id
30bba454f53ba2ec
Approval Number
国药准字HJ20170209
Generic Name
炔雌醇环丙孕酮片
Generic Name En
Ethinylestradiol and Cyproterone Acetate Tablets
Trade Name
达英-35
Drug Type
化学药品
Dosage Form
片剂
Strength
醋酸环丙孕酮2mg和炔雌醇0.035mg
Reg Date
2023-01-04
Expired Date
2028-01-03
Company Name
BAYER (SOUTH EAST ASIA) PTE LTD
Production Company Name
Bayer Weimar GmbH und Co. KG
Company Detail Path
/organization/bayer-south-east-asia-pte-ltd
Production Company Detail Path
/organization/bayer-weimar-gmbh-und-co-kg
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Jan 4, 2023
Approval ID
30bba454f53ba2ec
Type
化学药品
Back to NMPA Approvals
